Latest Earnings Analysis

• Bilibili (BILI) Q4 2023: Advertising Share Jumps to 30%, Unlocking Margin Expansion Path
  March 07, 2024 · BILI
• AKA Brands (AKA) Q4 2023: U.S. Sales Up 12% as Omnichannel and Inventory Reset Drive Strategic Shift
  March 07, 2024 · AKA
• AFC Gamma (AFCG) Q4 2023: Cannabis Pipeline Grows to $279M as Pure-Play Focus Returns
  March 07, 2024 · AFCG
• Amplify Energy (AMPY) Q4 2023: Net Debt Cut by $95M as Beta Development Ups Oil Mix
  March 07, 2024 · AMPY
• ARHS Q4 2023: Showroom Base Expands 20% as Strategic Investments Drive Long-Term Margin Leverage
  March 07, 2024 · ARHS
• Concrete Pumping Holdings (BBCP) Q1 2024: UK Revenue Jumps 21% as U.S. Weather Disrupts Core Margins
  March 07, 2024 · BBCP
• Altisource (ASPS) Q4 2023: $58M Sales Wins Position for 13%–32% Revenue Growth Ramp
  March 07, 2024 · ASPS
• Burlington Stores (BURL) Q4 2023: 130 Basis Point Margin Expansion Anchors $16B Growth Ambition
  March 07, 2024 · BURL
• Black Rifle Coffee (BRCC) Q4 2023: Wholesale Channel Surges 79%, Fueling Margin Expansion and Cash Flow Pivot
  March 07, 2024 · BRCC
• BJ’s (BJ) Q4 2023: General Merchandise Accelerates 1200bps, Unlocking Multi-Year Margin Upside
  March 07, 2024 · BJ
• American Outdoor Brands (AOUT) Q3 2024: Outdoor Lifestyle Hits 54% of Sales as Innovation Drives Channel Expansion
  March 07, 2024 · AOUT
• Airgain (AIRG) Q4 2023: Enterprise Rebounds 40% QoQ as Inventory Headwinds Ease
  March 06, 2024 · AIRG
• Allient (ALNT) Q4 2023: Industrial Segment Jumps 23% as “Simplify to Accelerate” Reshapes Margin Path
  March 06, 2024 · ALNT
• Abercrombie & Fitch (ANF) Q4 2023: Operating Margin Jumps to 15.3% as Brand Playbook Delivers Global Growth
  March 06, 2024 · ANF
• BBVA Argentina (BBAR) Q4 2023: Digital Sales Hit 93%, Market Share Rises Despite Loan Contraction
  March 06, 2024 · BBAR
• Aquestive Therapeutics (AQST) Q4 2023: Royalty Revenue Jumps 104% as Oral Rescue Pipeline Nears Pivotal Milestones
  March 06, 2024 · AQST
• AudioEye (AEYE) Q4 2023: Gross Margin Climbs to 78% as Operating Leverage Sets Up Accelerated Growth
  March 06, 2024 · AEYE
• BrainsWay (BWAY) Q4 2023: 50% Revenue Surge Anchors Breakout Profitability and International Expansion
  March 06, 2024 · BWAY
• Broadwind (BWEN) Q4 2023: AMP Credit Monetization Lifts EBITDA by Over $4M Amid Wind Market Lull
  March 05, 2024 · BWEN
• Axogen (AXGN) Q4 2023: Scheduled Procedures Surge 25%, Core Account Penetration Deepens
  March 05, 2024 · AXGN
• APEI Q4 2023: APUS Margin Soars to 35% as Enrollment Mix and Cost Cuts Drive Outperformance
  March 05, 2024 · APEI
• Amer Sports (AS) Q4 2023: Arc'teryx DTC Soars 42% as Premium Mix Drives Margin Expansion
  March 05, 2024 · AS
• Box (BOX) Q4 2024: Suites Penetration Jumps to 55%, Accelerating Platform Monetization
  March 05, 2024 · BOX
• Angel Oak Mortgage (AOMR) Q4 2023: Book Value Jumps 10.4% as Loan Rotation Nears Completion
  March 05, 2024 · AOMR
• AVAV Q3 2024: Loitering Munitions Revenue Surges 140%, Driving Record Backlog and Double-Digit Growth Trajectory
  March 04, 2024 · AVAV
• Biodesix (BDSX) Q4 2023: Lung Test Volumes Surge 65% as Margin Expansion Accelerates
  March 01, 2024 · BDSX
• Braemar Hotels (BHR) Q4 2023: Group Revenue Up 15%, Urban Recovery Drives 2024 Growth Narrative
  March 01, 2024 · BHR
• Acme United (ACU) Q4 2023: First Aid Mix Climbs to 60%, Unlocking Margin Expansion and Growth Focus
  March 01, 2024 · ACU
• Buenaventura (BVN) Q4 2023: Copper Output Hits 58k Tons, San Gabriel Drives $127M CAPEX Surge
  March 01, 2024 · BVN
• Ameren (AMRN) Q4 2023: Europe Product Revenue Jumps 65% as Global Expansion Drives Optionality
  February 29, 2024 · AMRN
• AvePoint (AVPT) Q4 2023: SaaS Revenue Climbs 37% as AI-Readiness Drives Platform Expansion
  February 29, 2024 · AVPT
• ARGX Q4 2023: VivGuard Drives $1.2B U.S. Revenue as Pipeline Readies for Five New Indications
  February 29, 2024 · ARGX
• Arlo (ARLO) Q4 2023: Service Revenue Jumps 47% as Paid Subscribers Top 3 Million
  February 29, 2024 · ARLO
• Brinks (BCO) Q4 2023: AMS and DRS Revenue Hits 21% of Mix, Doubling Free Cash Flow
  February 29, 2024 · BCO
• Birkenstock (BIRK) Q1 2024: Closed-Toe Mix Surges to 53%, Unlocking Premium Price Tailwind
  February 29, 2024 · BIRK
• Capricor Therapeutics (CAPR) Q4 2023: $10M Milestone Payment Signals Accelerated BLA Path for CAP-1002
  February 29, 2024 · CAPR
• Best Buy (BBY) Q4 2024: Membership Drives 45bps Margin Expansion as Tech Cycles Reignite
  February 29, 2024 · BBY
• Barfresh (BRFH) Q4 2023: Carton Capacity Ramps 25M Units, Unlocking School Channel Growth
  February 29, 2024 · BRFH
• Ashford Hospitality Trust (AHT) Q4 2023: $225M Asset Sales Pipeline Drives Strategic Deleveraging
  February 29, 2024 · AHT
• ANI Pharmaceuticals (ANIP) Q4 2023: Cortrophin Gel Jumps 137% as Rare Disease Expansion Accelerates
  February 29, 2024 · ANIP
• Bath & Body Works (BBWI) Q4 2023: Merchandise Margin Expands 290bps as Adjacencies Scale
  February 29, 2024 · BBWI
• Acres Commercial Realty (ACR) Q4 2023: Share Buybacks Add $1.32 Per Share to Book Value Amid Portfolio Risk Shift
  February 29, 2024 · ACR
• BrightSpring (BTSG) Q4 2023: Pharmacy Revenue Jumps 30% as Integrated Care Drives Platform Expansion
  February 29, 2024 · BTSG
• BioLife Solutions (BLFS) Q4 2023: Freezer Exit to Lift Margins as Cell Processing Climbs 11% Sequentially
  February 29, 2024 · BLFS
• ACI Worldwide (ACIW) Q4 2023: Biller Segment EBITDA Surges 60%, Unlocking Margin Expansion Momentum
  February 29, 2024 · ACIW
• AB InBev (BUD) Q4 2023: $40B Digital GMV Signals Ecosystem Monetization Shift
  February 29, 2024 · BUD
• Advantage Solutions (ADV) Q4 2023: $532M Divestitures Streamline Core, Capital Outlays Signal Tech-Driven Reset
  February 29, 2024 · ADV
• American Coastal (ACIC) Q4 2023: Commercial Lines Combined Ratio Improves 17.5 Points, Capitalizing on Florida Market
  February 29, 2024 · ACIC
• Autodesk (ADSK) Q4 2024: New Transaction Model Adds $600M Revenue Visibility, Reshaping Go-to-Market
  February 29, 2024 · ADSK
• Arbutus Biopharma (ABUS) Q4 2023: Cash Burn Cut 26% as Pipeline Focus Narrows to Hepatitis B Cure
  February 29, 2024 · ABUS